BACKGROUND: Despite the existence of international guidelines, vaccination in patients with inflammatory bowel disease (IBD) has not been integrated optimally. We developed a thorough education program, and compared its influence on vaccination rates with routine clinical practice in a tertiary IBD center. METHODS: Between December 2014 and March 2015, we included 505 consecutive patients with IBD visiting our outpatient clinic (53% men, 72% Crohn's disease, median age 44 years). Vaccination data, including hepatitis B, influenza, pneumococcus, tetanus, and varicella zoster virus, as well as demographic data, were collected by a fellow in training or a certified gastroenterologist. Thereafter, patients were randomly assigned to group A re...
International audienceBackground: Despite specific immunization guidelines for immunocompromised pat...
Objectives:We aimed to determine vaccination practices of pediatric gastroenterologists, as well as ...
Background: Vaccination against COVID-19 is a major public health challenge, including the community...
Immunosuppressive agents used to treat inflammatory bowel disease (IBD) can increase the risk for in...
Introduction: Opportunistic infections are a key safety concern in the management of patients with i...
International audienceBACKGROUND: Children with inflammatory bowel disease are at risk of vaccine-pr...
This article has an accompanying continuing medical education activity on page e130 (https://www.sci...
Treatment of inflammatory bowel disease (IBD) frequently requires administration of immunosuppressiv...
Background: Immunomodulators and biological agents, used to treat inflammatory bowel disease [IBD], ...
International audienceBackgroundA better patient’s knowledge on their Inflammatory Bowel Disease (IB...
Background/Aims Long-term immunosuppressive therapies used to treat inflammatory bowel disease (IBD)...
International audienceBackground: Despite specific immunization guidelines for immunocompromised pat...
Objectives:We aimed to determine vaccination practices of pediatric gastroenterologists, as well as ...
Background: Vaccination against COVID-19 is a major public health challenge, including the community...
Immunosuppressive agents used to treat inflammatory bowel disease (IBD) can increase the risk for in...
Introduction: Opportunistic infections are a key safety concern in the management of patients with i...
International audienceBACKGROUND: Children with inflammatory bowel disease are at risk of vaccine-pr...
This article has an accompanying continuing medical education activity on page e130 (https://www.sci...
Treatment of inflammatory bowel disease (IBD) frequently requires administration of immunosuppressiv...
Background: Immunomodulators and biological agents, used to treat inflammatory bowel disease [IBD], ...
International audienceBackgroundA better patient’s knowledge on their Inflammatory Bowel Disease (IB...
Background/Aims Long-term immunosuppressive therapies used to treat inflammatory bowel disease (IBD)...
International audienceBackground: Despite specific immunization guidelines for immunocompromised pat...
Objectives:We aimed to determine vaccination practices of pediatric gastroenterologists, as well as ...
Background: Vaccination against COVID-19 is a major public health challenge, including the community...